Endoplasmic reticulum stress inhibition blunts the development of essential hypertension in the spontaneously hypertensive rat.

Authors:
Safaa Naiel
Safaa Naiel
McMaster University
Rachel E Carlisle
Rachel E Carlisle
McMaster University and St. Joseph's Healthcare Hamilton
Canada
Chao Lu
Chao Lu
Beijing University of Chemical Technology
China
Victor Tat
Victor Tat
Firestone Institute for Respiratory Health
Jeffrey G Dickhout
Jeffrey G Dickhout
McMaster University
Canada

Am J Physiol Heart Circ Physiol 2019 May 8;316(5):H1214-H1223. Epub 2019 Mar 8.

Department of Medicine, Hamilton Centre for Kidney Research, McMaster University and St. Joseph's Healthcare Hamilton , Hamilton, Ontario , Canada.

Essential hypertension is the leading cause of premature death worldwide. However, hypertension's cause remains uncertain. endoplasmic reticulum (ER) stress has recently been associated with hypertension, but it is unclear whether ER stress causes hypertension. To clarify this question, we examined if ER stress occurs in blood vessels before the development of hypertension and if ER stress inhibition would prevent hypertension development. We used the spontaneously hypertensive rat (SHR) as a model of human essential hypertension and the Wistar-Kyoto (WKY) rat as its normotensive control. Resistance arteries collected from young rats determined that ER stress was present in SHR vessels before the onset of hypertension. To assess the effect of ER stress inhibition on hypertension development, another subset of rats were treated with 4-phenylbutyric acid (4-PBA; 1 g·kg·day) for 8 wk from 5 wk of age. Blood pressure was measured via radiotelemetry and compared with untreated SHR and WKY rats. Mesenteric resistance arteries were collected and assessed for structural and functional changes associated with hypertension. Systolic and diastolic blood pressures were significantly lower in the 4-PBA-treated SHR groups than in untreated SHRs. Additionally, 4-PBA significantly decreased the media-to-lumen ratio and ER stress marker expression, improved vasodilatory response, and reduced contractile responses in resistance arteries from SHRs. Overall, ER stress inhibition blunted the development of hypertension in the SHR. These data add evidence to the hypothesis that a component of hypertension in the SHR is caused by ER stress. In this study, 4-phenylbutyric acid's (4-PBA's) molecular chaperone capability was used to inhibit endoplasmic reticulum (ER) stress in the small arteries of young spontaneously hypertensive rats (SHRs) and reduce their hypertension. These effects are likely mediated through 4-PBA's effects to reduce resistant artery contractility and increase nitric oxide-mediated endothelial vasodilation through a process preventing endothelial dysfunction. Overall, ER stress inhibition blunted the development of hypertension in this young SHR model. This suggests that a component of the increase in blood pressure found in SHRs is due to ER stress. However, it is important to note that inhibition of ER stress was not able to fully restore the blood pressure to normal, suggesting that a component of hypertension may not be due to ER stress. This study points to the inhibition of ER stress as an important new physiological pathway to lower blood pressure, where other known approaches may not achieve blood pressure-lowering targets.

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpheart.00523.2018DOI Listing
May 2019
1 Read

Publication Analysis

Top Keywords

stress inhibition
20
stress
16
blood pressure
16
hypertension
15
development hypertension
12
essential hypertension
12
reticulum stress
12
resistance arteries
12
endoplasmic reticulum
12
spontaneously hypertensive
12
hypertension stress
8
hypertension shr
8
shrs stress
8
associated hypertension
8
inhibition blunted
8
blunted development
8
arteries collected
8
component hypertension
8
inhibition stress
8
hypertension development
8

References

(Supplied by CrossRef)

Similar Publications